Chiltern CRO announces launch of Collaborative Technologies

Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced the launch of Collaborative Technologies.

"Chiltern's Collaborative Technologies is a turnkey solution reflecting integrated processes and technology which offers a single access point to clinical study data and the central document repository for the entire study team. Our Data Warehousing brings together data from core clinical systems to present one consolidated view of information," stated Dr Jim Esinhart, Chiltern Executive Vice President, Global Biometrics and North America.  

Glenn Kerkhof, Chiltern CEO, commented, "A key benefit of Collaborative Technologies is the immediate access to current study information which the entire study team can access wherever they are located globally. This means faster decisions can be made on the study which results in time and cost savings for our clients."

Dr Esinhart added, "In addition to the core components in the Collaborative Technologies platform, it has been configured to work with Chiltern's proprietary systems such as Chiltern Insight, our clinical trial management system, and Chiltern Safe, our Trial Master File and Electronic Records Management system. We are extremely pleased to report that Collaborative Technologies works hand-in-hand with our industry's leading systems such as Medidata Rave® and Clinphone Datalabs® for Electronic Data Capture (EDC), Phase Forward's Empirica™ Trace for adverse event management and endpoint's PULSE for Interactive Response Technology (IRT). To summarize, Collaborative Technologies offers our clients a suite of best-in-class technological solutions for their clinical trial needs under one organization."